{
  "company": {
    "name": "interface.bio",
    "website": "https://interface.bio/",
    "record": "https://startuphistory.org/c/interface.bio"
  },
  "status": null,
  "history_since": "2018-08-03T22:28:03.000Z",
  "baseline": {
    "snapshot_id": "15e28db050a7387f795b5de7b37ecb881854fc36e182aecd3f1615266a1ac0b0",
    "observed_at": "2018-08-03T22:28:03.000Z",
    "headline": "Interface Biosciences",
    "description": "Welcome to Interface Biosciences Bridging the gap between the human microbiome and immune system Our mission At Interface Biosciences, we focus on the investigating the interaction between the human m",
    "evidence": "https://web.archive.org/web/20180803222803/http://interface.bio/",
    "evidence_kind": "internet_archive",
    "facts": null,
    "basis": "first_observation",
    "is_change": false
  },
  "live_captures": 1,
  "last_checked": "2026-11-06T17:24:20.950Z",
  "live_status": null,
  "messaging": [
    {
      "quote_observed_at": "2024-03-14T02:33:04.000Z",
      "variants": [
        {
          "headline": "Interface Biosciences",
          "subhead": "Welcome to Interface Biosciences Bridging the gap between the human microbiome and immune system Our mission At Interface Biosciences, we focus on the investigating the interaction between the human m",
          "observed_at": "2018-08-03T22:28:03.000Z",
          "evidence": "https://web.archive.org/web/20180803222803/http://interface.bio/",
          "evidence_kind": "internet_archive"
        },
        {
          "headline": "Interface Biosciences",
          "subhead": "Defining the future of microbiome therapeutics. Interface Biosciences is a platform therapeutics company leveraging the microbiome to treat inflammatory disease. We are driven by the conviction that m",
          "observed_at": "2022-01-28T10:29:30.000Z",
          "evidence": "https://web.archive.org/web/20220128102930/https://interface.bio/",
          "evidence_kind": "internet_archive"
        },
        {
          "headline": "Interface Biosciences",
          "subhead": "Defining the future of microbiome therapeutics. Interface Biosciences is a platform therapeutics company leveraging the microbiome to treat inflammatory disease. We are driven by the conviction that m",
          "observed_at": "2022-07-12T07:37:08.000Z",
          "evidence": "https://web.archive.org/web/20220712073708/https://interface.bio/",
          "evidence_kind": "internet_archive"
        },
        {
          "headline": "Interface Biosciences",
          "subhead": "Defining the future of microbiome therapeutics. Interface Biosciences is a platform therapeutics company leveraging the microbiome to treat inflammatory disease. We are driven by the conviction that m",
          "observed_at": "2023-02-09T13:12:25.000Z",
          "evidence": "https://web.archive.org/web/20230209131225/https://interface.bio/",
          "evidence_kind": "internet_archive"
        },
        {
          "headline": "Interface Biosciences",
          "subhead": "We are an AI-enabled, metabolomics-based drug discovery engine for inflammatory disease. Inflammatory Disease is a huge unmet need. Inflammatory bowel disease, eczema, and rheumatoid arthritis all hav",
          "observed_at": "2023-11-17T13:44:26.000Z",
          "evidence": "https://web.archive.org/web/20231117134426/https://interface.bio/",
          "evidence_kind": "internet_archive"
        },
        {
          "headline": "Interface Biosciences",
          "subhead": "We are an AI-enabled, metabolomics-based drug discovery engine for inflammatory disease. Inflammatory Disease is a huge unmet need. Inflammatory bowel disease, eczema, and rheumatoid arthritis all hav",
          "observed_at": "2024-03-14T02:33:04.000Z",
          "evidence": "https://web.archive.org/web/20240314023304/https://interface.bio/",
          "evidence_kind": "internet_archive"
        }
      ],
      "headline": "Interface Biosciences",
      "subhead": "We are an AI-enabled, metabolomics-based drug discovery engine for inflammatory disease. Inflammatory Disease is a huge unmet need. Inflammatory bowel disease, eczema, and rheumatoid arthritis all hav",
      "from": "2018-08-03T22:28:03.000Z",
      "to": "2024-03-14T02:33:04.000Z",
      "captures": 6,
      "evidence": "https://web.archive.org/web/20240314023304/https://interface.bio/",
      "evidence_kind": "internet_archive",
      "seen": {
        "between": {
          "from": "2018-08-03T22:28:03.000Z",
          "to": "2024-03-14T02:33:04.000Z"
        }
      },
      "current": true
    }
  ],
  "changes": [
    {
      "n": 1,
      "id": "page-f5182f56a7188a2ce3486b1b64a8052eba7c225a81f1a020574bf7edba65c5d8:bfabaff9eb4534171244d57dd34eb396dc1fa7884b306fdaa0b7fa608728bfbe:hiring:20dd4c09cc4ab0aa",
      "before_evidence": "https://web.archive.org/web/20240915202931/https://www.interface.bio/",
      "before_evidence_kind": "internet_archive",
      "kind": "hiring",
      "label": "Hiring",
      "summary": "Added a careers page.",
      "between": {
        "from": "2024-09-15T20:29:31.000Z",
        "to": "2025-02-07T18:26:48.000Z"
      },
      "evidence": "https://web.archive.org/web/20250207182648/https://interface.bio/",
      "evidence_kind": "internet_archive",
      "basis": "page_facts",
      "topic": "https://startuphistory.org/t/added-careers-page"
    }
  ],
  "update": null,
  "method": {
    "version": "messaging-v1",
    "description": "https://startuphistory.org/method"
  },
  "license": "CC-BY-4.0",
  "cite": "StartupHistory, “interface.bio” company record, https://startuphistory.org/c/interface.bio"
}